SUMMARY The interaction between smoking and the effect of histamine H2-antagonists on intragastric acidity was examined in a double blind double dummy placebo controlled study. Healthy volunteers, 11 smokers and 10 non-smokers, were given, on four separate days at least one week apart, either placebo or cimetidine 800 mg nocte or ranitidine 2x 150 mg per day or ranitidine 300 mg nocte. Tablets were taken at 2115 and 0900 h. Smokers smoked a cigarette hourly from 0700 to 2300 h. Breakfast, lunch, and dinner were standardised. Intragastric acidity was measured with a combined intragastric glass electrode and a solid state recorder. The subjects were fully ambulatory. The three histamine H2-receptor antagonist regimens were less effective (p=004) in smokers than in non-smokers, but the difference between acidity of smokers and non-smokers was small. Means of medians of pH during a 24-h period with placebo, cimetidine 800 mg, raniditine 2x 150 mg and ranitidine 300 mg were 1-6, 2 3, 3-1, and 2-7 in smokers and 1-5, 2.7, 3*2, and 3-1 in non-smokers, respectively. In a second part of the study seven chronic smokers were reexamined after acutely stopping smoking: inhibition of gastric acidity by histamine H2-receptor antagonists was similar before and after withdrawal. Smoking does not affect intragastric acidity in untreated volunteers and only slightly decreases the effectiveness of histamine H2-receptor antagonists on intragastric acidity. This effect best in part explains the unfavourable effect of smoking on healing of peptic ulcer in patients treated with these drugs.
volunteers. Eleven smokers (seven women, mean age 24 years, range 19-37 years) and 10 non-smokers (six women, mean age 25 years, range 19-30 years) agreed to participate. The mean body weight was smokers: 66 kg (range 52-79), non-smokers: 62 kg (range . Smokers were those who had been smoking at least 10 cigarettes every day for at least one year. Non-smokers had not been smoking at all before. None of the volunteers had a history of gastrointestinal diseases or was taking other drugs. Each volunteer was completed a 'Freiburg personality inventory' (FPI), a modified neuroticismextroversion-test.' Twelve different FPI-scores were evaluated in smokers and non-smokers, but no differences between the two groups could be detected. Care was taken to include only subjects who tolerated the procedure well and did not experience discomfort or nausea while smoking or at night. All slept well, ate their standardised meals completely and followed their usual activities on the study days. Seven of the 11 smokers agreed to participate in 549 a crossover study with multiple acute withdrawals of smoking. Informed consent was given. The trial was approved by the hospital ethics committee. STUDY 
SCHEDULE AND MEDICATION
Each volunteer received on four separate days at least one week apart either placebo (P), or cimetidine 800 mg nocte (Cim 800), or ranitidine 300 mg nocte (Ran 300), or ranitidine 2 x 150 mg per day (Ran 150) in a sequential random order. The study was conducted in a double blind fashion using a double dummy tablet technique. In the first part of the study, smokers smoked hourly one cigarette amounting to a total of 17 cigarettes per day. Non-smokers did not smoke. In the second part of the study seven smokers were reexamined 24 hours after stopping smoking.
EXPERIMENTAL DESIGN
The time course of the experiment is given in Figure  1 . On the study day the volunteers started to fast at 1200 h and were admitted to our laboratory before 1600 h. A pH electrode was placed through the nares in the gastric body. The position of the electrode was verified fluoroscopically. The volunteers received the medication and a pack containing four standardised meals for the following 24 hours. Composition and energy content of the meals are given in Table 1 . Water and unsweetened tea were allowed ad libitum. The subjects were given a diary card in which times of meals, medication and time of smoking of cigarettes was specified. The volunteers were also asked to record their daily activities, pain, hunger, sleep and fluid intake. The subjects were fully ambulatory. They returned to the hospital at 2300 h for collection of a blood sample for the measurement of carboxyhaemoglobin, cimitedine, and ranitidine. At 1600 h next day, the pH-electrode was removed and a second blood sample was taken. The time course of intragastric acidity during the various treatments is shown in Figure 2 . Intragastric pH exhibited a characteristic circadian rhythm. In each individual lunch and dinner was associated with raised intragastric pH. The mean curve clearly shows the effect of lunch; the effect of dinner was less pronounced. pH rose during the night, particularly between 0200 h and 0700 h; breakfast did not lead to an additional rise of intragastric pH.
HOUR pH INTRAGASTRIC ACIDITY WITH HISTAMINE H2-RECEPTOR ANTAGONISTS
Intragastric acidity during treatment with Cim 800, Ran 150 or Ran 300 showed a circadian pattern which was similar in smokers, non-smokers and smokers after stopping smoking both with cimetidine and ranitidine. All three regimes raised the nocturnal pH. The effectiveness of Cim 800, Ran 300, and Ran 150 over a 24 hour period is given in Table 2 for the first part of the study and in Table 3 for the crossover part; Table  4 . With respect to intensity and area under the curve, cimetidine was less effective than ranitidine.
INTERACTION OF DRUG EFFECT AND SMOKING
The pH curves of smokers, non-smokers and smokers after withdrawal from smoking are shown in Figure 2 . Overall, the pH-curves of smokers and nonsmokers and of smokers and smokers who stopped smoking were similar. In an analysis of variance ( smokers before and after they stopped smoking was obtained; this is illustrated in Figure 3 . Furthermore, acutely stopping smoking did not affect the effect of histamine H2-antagonists (ANOVA , Table 3 ). Duration, latency, intensity and area under the curve after administration of histamine H2-receptor antagonists were not affected by smoking (Table 4) .
COMPLIANCE, DRUG AND CARBOXYHAEMOGLOBIN SERUM LEVELS
Serum ranitidine concentrations were in the therapeutic range in all subjects taking ranitidine, serum cimetidine concentrations in all subjects taking cimetidine, and carboxyhaemoglobin was raised in all Drug factor, smoking factor, and interaction term are explained in Table 3 .
smoking subjects. There was no overlap of carboxyhaemoglobin concentrations between smokers and non-smokers. Serum drug concentrations were equal in smokers, non-smokers and smokers after withdrawal from smoking (Mann-Whitney-U test). Mean values are shown in Table 5 .
Discussion
In the present study we were unable to observe an effect of smoking on spontaneous intragastric acidity. As in our previous studies using intragastric pHmetry, there was a characteristic circadian pattern of intragastric pH."4' This pattern was similar in smokers and in non-smokers. In addition, the smokers maintained this pattern after acutely stopping smoking. So far the effect of smoking on intragastric acidity and gastric secretion has not been satisfactorily determined. The first studies on this subject either Drug factor, smoking factor, and interaction term are explained in Table 3 . Table 5 Blood concentrations at 2300 h of carbo rylaemoglobin (HbCO), cimetidine and ranitidine (meanis ± SEM). HbCO showed an increase of gastric acidity by smoking in healthy controls and ulcer patients,"5 or no consistent effect."7 In more recent studies gastric acidity or gastric acid output were examined: either no effect,)-' or a decrease,5" or stimulation,5747 or inhibition followed by stimulation534 were reported. These studies were not adequately controlled, smoking was not standardised, the effect of smoking was only assessed during short periods of a few hours or it was not even mentioned if the smokers smoked during the study, or whether the gastric tube or smoking after intubation caused discomfort or nausea. Gastric acidity was assessed by intermittent gastric aspiration which may on its own affect gastric secretion4"49 and therefore may lead to artefacts. In the present study smoking was standardised, smokers were compared with non-smokers and served, in the crossover part of the study, as their own controls after stopping smoking. Smokers stopped smoking 24 hours before repeating the study. This period is long enough to reduce nicotine levels in the plasma to values of non-smokers.5" Intragastric acidity was assessed by continuous standardised 24-hour pHmetry, which has been validated previously and shown to be reliable."5 All subjects were well adapted to this method. We observed that smoking interfered with the effect of histamine H2-receptor antagonists on intragastric acidity. Ranitidine and cimetidine were less potent in smokers than in non-smokers. The difference between smokers and non-smokers, although statistically significant, however, was slight and amounted to less than half of a pH unit. Ranitidine and cimetidine were highly effective in non-smokers as well as in smokers. As in previous studies, ranitidine had a more pronounced antisecretory effect than cimetidine.555' It has been suggested by Boyd, et 
